← All stocks

LENSAR, Inc.

LNSR Net buying

CIK 0001320350 #4317 in the set updated 22 Sep 2026

Bought (120 mo)

$322.78K

out of their own pocket, the only kind of buying there is

Sold (120 mo)

$0.00

$0.00 on a plan · $0.00 straight out of an exercise

Sold at will

$0.00

0 of 0 sales

Net

+$322.78K

+$322.78K against sales at will

By person

13 insiders · 32 transactions

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

WEISNER AIMEE S

Director

$131.27K (4)

—

+$131.27K

110,368

0.8983%

$496.66K

—

PDL BIOPHARMA, INC. entity

10% owner

$97.13K (1)

—

+$97.13K

0.0000%

$0.00

−100.0%

Winer Gary M

Director

$85.69K (23)

—

+$85.69K

105,635

0.8598%

$475.36K

+398.5%

STAAB THOMAS R II

Chief Financial Officer

$8.70K (2)

—

+$8.70K

174,609

1.42%

$785.74K

+78.0%

CURTIS NICHOLAS T

Chief Executive Officer

—

1,122,758

9.14%

$5.05M

+79.9%

LINK WILLIAM J PHD

Director

—

568,062

4.62%

$2.56M

+32.9%

Connaughton Alan B.

Chief Operating Officer

—

389,173

3.17%

$1.75M

+83.5%

LINDSTROM RICHARD L MD

Director

—

263,831

2.15%

$1.19M

+54.0%

O'Farrell Elizabeth G.

Director

—

67,368

0.5483%

$303.16K

+862.4%

Wong Kendra

Principal Accounting Officer

—

56,481

0.4597%

$254.16K

+245.7%

ELLIS THOMAS B

Director

—

56,083

0.4565%

$252.37K

—

HAMMER TODD B

Director

—

56,083

0.4565%

$252.37K

—

MCLAUGHLIN JOHN PETER

Director

—

53,631

0.4365%

$241.34K

+33.9%

Individual transactions

Nothing of that kind in this period.

What was left out

Form 4 filings counted 106

Amendments (4/A) skipped 0

Filings about a different issuer 0

Unreadable filings 0

Joint filings 0

Sales on a Rule 10b5-1 plan 0

Sales straight out of an exercise 0

Sales at will 0

Transactions with no price 0

Shares from compensation/vesting 10,040,101

History held since 1 Oct 2020